A critical review of the literature to conduct a toxicity assessment for oral exposure to methyl salicylate

References

• Abbot DD, Harrisson JWE. 1978. Methyl salicylate: studies of osseous changes in the rat, reproduction in the rat and mouse, and liver and kidney effects in the dog. Unpublished communication to the Flavor and Extract Manufacturers Association (As cited in CIR 2003, NFSA 2012).
   Google Scholar
• Allen BC, Kavlock RJ, Kimmel CA, Faustman EM. 1994. Dose-response assessment for developmental toxicity. III. Statistical Models. Fund Appl Toxicol. 23:496–509.
   PubMedGoogle Scholar
• Battino M, Ferreiro MS, Armeni T, Politi A, Bompadre S, Massoli A, Bullon P. 2005. In vitro antioxidant activities of antioxidant-enriched toothpastes. Free Radic Res. 39:343–350.
   PubMed Web of Science ®Google Scholar
• Beck BD, Clewell HJ III. 2001. Uncertainty/safety factors in health risk assessment: opportunities for improvement. Hum Ecol Risk Assess. 7:203–207.
   Web of Science ®Google Scholar
• Cerletti C, Dell'Elba G, Manarini S, Pecce R, Di Castelnuovo A, Scorpiglione N, Feliziani V, de Gaetano G. 2003. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes. Clin Pharmacokinet. 42:1059–1070.
   PubMed Web of Science ®Google Scholar
• ChemSpider. 2015. Search and share chemistry [Internet]. Royal Society of Chemistry. [cited 2016 Apr 14]. Available from: http://www.chemspider.com/Chemical-Structure.13848808.html?rid =56c5d453-3418-4c23-9d07-6dbb9d658fd2.
   Google Scholar
• Chen C, Isabelle LM, Pickworth WB, Pankow JF. 2010. Levels of mint and wintergreen flavorants: smokeless tobacco products vs. confectionary products. Food Chem Toxicol. 49:755–763.
   PubMed Web of Science ®Google Scholar
• Code of Federal Regulations. 2015. From the U.S. Government Printing Office via GPA access. Title 21, vol. 3, part 175. [cited 2016 Aug 31]; Available from: http://www.ecfr.gov/cgi-bin/text-idx?SID=a52bd4f6a793316bc823387b87c80829&mc=true&node=pt21.3.175&rgn=div5#se21.3.175_1105.
   Google Scholar
• [CIR] Cosmetic Ingredient Review. 2003. Safety assessment of salicylic acid, butyloctyl salicylate, calcium salicylate, C12-15 alkyl salicylate, capryloyl salicylic acid, hexyldodecyl salicylate, isocetyl salicylate, isodecyl salicylate, magnesium salicylate, MEA- salicylate, ethylhexyl salicylate, potassium salicylate, methyl salicylate, myristyl salicylate, sodium salicylate, TEA- salicylate, and tridecyl salicylate. Int J Toxicol. 22 Suppl 3:1–108.
   Google Scholar
• [CIR] Cosmetic Ingredient Review. 2008. Final report of the safety assessment of alcohol denaturants, including SD alcohol 3-A, SD alcohol 30, SD alcohol 39, SD alcohol 39-B, SD alcohol 39-C, SD alcohol 40, SD alcohol 40-B, and SD alcohol 40-C, and the denaturants, quassin, brucine sulfate/brucine, and denatonium benzoate. Int J Toxicol. 27 Suppl 1:1–43.
   Google Scholar
• Collins TF, Hansen WH, Keeler HV. 1971. Effect of methyl salicylate on rat reproduction. Toxicol Appl Pharmacol. 18:755–765.
   PubMed Web of Science ®Google Scholar
• Crossland AM. 1948. Methyl salicylate poisoning. Can Med Assoc J. 58:75–77.
   PubMed Web of Science ®Google Scholar
• Daston GP, Rehnberg BF, Carver B, Rogers E, Kavlock R. 1988. Functional teratogens of the rat kidney. I. Colchicine, dinoseb, and methyl salicylate. Fundam Appl Toxicol. 11:381–400.
   PubMedGoogle Scholar
• Davis LE, Westfall BA. 1972. Species differences in biotransformation and excretion of salicylate. Am J Vet Res. 33:1253–1262.
   PubMed Web of Science ®Google Scholar
• Davison C, Zimmerman EF, Smith P. 1961. On the metabolism and toxicity of methyl salicylate. J Pharmacol Exp Ther. 132:207–211.
   PubMed Web of Science ®Google Scholar
• Dorne JL. 2004. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation. Fundam Clin Pharmacol. 18:609–620.
   PubMed Web of Science ®Google Scholar
• [EFSA] European Food Safety Authority. 2012. Scientific opinion on the safety and efficacy of benzyl alcohols, aldehydes, acids, esters and acetals (chemical group 23) when used as flavorings for all animal species. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). EFSA J. 10:2785. doi: 10.2903/j.efsa.2012.2785.
   Google Scholar
• Gatti G, Barzaghi N, Attardo Parrinello G, Vitiello B, Perucca E. 1989. Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects. Int J Clin Pharm Res. 9:385–389.
   PubMedGoogle Scholar
• Graham GG, Roberts MS, Day RO, Rainsford KD. 2004. Pharmacokinetics and metabolism of the salicylates. In: Rainsford KD, editor. Aspirin and related drugs. New York: Taylor and Francis, p. 97–155 (Chapter 4).
   Google Scholar
• Gulati DK, Choudhury H, Chambers R, Sabharwal PS, Lamb JIV. 1984. Methyl salicylate: fertility assessment in cd-1 mice when administered by gavage. National Toxicology Program, National Institutes of Environmental Health Sciences. NTP-85-022. Available from: https://www.ntis.gov/products/ntrl/.
   Google Scholar
• Harrisson JWE, Abbott DD, and Packman EW. 1963. Salicylates and other hydroxybenzoates: effect upon osseous tissue of young rats. Federation Proceedings, vol. 22, p. 554.
   Google Scholar
• Hutt AJ, Caldwell J, Smith R. 1986. The metabolism of aspirin in man: a population study. Xenobiotica. 16:239–249.
   PubMed Web of Science ®Google Scholar
• Infurna R, Beyer B, Twitty L, Koehler G, Daughtrey W. 1990. Evaluation of the dermal absorption and teratogenic potential of methyl salicylate in a petroleum-based grease. East Millstone (NJ): Exxon Biomedical Sciences, Inc. Teratology. 41:566.
   Google Scholar
• [IPCS] International Program on Chemical Safety. (1987). Environmental Health Criteria 70. Principles for the safety assessment of food additives and contaminants in food. World Health Organization, Geneva. Available from: http://www.inchem.org/documents/ehc/ehc/ehc70.htm#SectionNumber:5.5.
   Google Scholar
• Ishidate M, Sofuni T, Yoshikawa D, Hayashi M, Nohmi T, Sawada M, Matsuoka A. 1984. Primary mutagenicity screening of food additives currently used in Japan. Food Chem Toxicol. 22:623–636.
   PubMed Web of Science ®Google Scholar
• [JECFA] Joint FAO/WHO Expert Committee on Food Additives. 1968. Specifications for the identity and purity of food additives and their toxicological evaluation: some flavoring substances and non-nutritive sweetening agents. Eleventh report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization Technical Report Series No. 383, FAO Nutrition Meetings Report Series No. 44, Geneva.
   Google Scholar
• [JECFA] Joint FAO/WHO Expert Committee on Food Additives. 2002. Evaluation of certain food additives and contaminants. Fifty-seventh report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 909. Geneva: World Health Organization.
   Google Scholar
• Klimisch HJ, Andreae M, Tillmann U. 1997. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol. 25:1–5.
   PubMed Web of Science ®Google Scholar
• Kroes R, Munro I, Poulsen E. 1993. Workshop on the scientific evaluation of the safety factor for the acceptable daily intake (ADI): editorial summary. Food Addit Contam. 10:269–273.
   PubMed Web of Science ®Google Scholar
• Kuboyama N, Fujii A. 1992. Mutagenicity of analgesics, their derivatives, and anti-inflammatory drugs with S-9 mix of several animal species. J Nihon Univ School Dentistry. 34:183–195.
   PubMedGoogle Scholar
• Lapczynski A, Jones L, McGinty D, Bhatia S, Letizia C, Api A. 2007. Fragrance material review on methyl salicylate. Food Chem Toxicol. 45(Suppl 1):S428–S452.
   PubMed Web of Science ®Google Scholar
• LaWall and Harrisson Research Laboratories, Inc. 1964. Study of Methyl Salicylate on rats. L&H 58188. (Submitted by FDA in response to an FOI request – 1998; 120 pages) (As cited in CIR 2003).
   Google Scholar
• Levy G, Weintraub L, Matsuzawa T, Oles S. 1966. Absorption, metabolism and excretion of salicylic phenolic glucuronide in rats. J Pharm Sci. 55:1319–1320.
   PubMed Web of Science ®Google Scholar
• Lewis RW, Billington R, Debryune E, Gamer A, Land B, Carpanini F. 2002. Recognition of adverse and nonadverse effects in toxicity studies. Toxicol Pathol. 30:66–74.
   PubMed Web of Science ®Google Scholar
• Lisko JG, Stanfill SB, Watson CH. 2014. Quantitation of ten flavor compounds in unburned tobacco products. Anal Methods. 6:4698–4704.
   PubMed Web of Science ®Google Scholar
• Lucker PW, Birkel M, Hey B, Loose I, Schaefer A. 2003. Pharmacokinetic interaction study of a fixed combination of 500 mg acetylsalicylic acid/30 mg pseudoephedrine versus each of the single active ingredients in healthy male volunteers. Arzneimittel-Forsch. 53:260–265.
   PubMed Web of Science ®Google Scholar
• Montgomery PR, Berger LG, Mitenko P, Sitar D. 1986. Salicylate metabolism: effects of age and sex in adults. Clin Pharmacol Therap. 39:571–576.
   PubMed Web of Science ®Google Scholar
• Morrissey RE, Lamb J, Morris R, Chapin R, Gulati D, Heindel J. 1989. Results and evaluations of 48 continuous breeding reproduction studies conducted in mice. Developmental and Reproductive Toxicology Group, NIEHS, NTP Program, Research Triangle Park, North Carolina, Analytical Sciences Inc., Durham, North Carolina, Environmental Health Research and Testing, Inc., Lexington, Kentucky. Fund Appl Toxicol. 13:747–777.
   Google Scholar
• Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, Zeiger E. 1986. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ Mutagen. 8(Suppl 7):1–119.
   PubMedGoogle Scholar
• Murugesh N, Kumar VR, Vembar S, Damodaran C. 1981. Studies on erythrocyte membrane. V. Haemolytic effect of methylsalicylate and its possible mechanism. Toxicol Lett. 9:225–229.
   PubMed Web of Science ®Google Scholar
• Needs CJ, Brooks PM. 1985. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet. 10:164–177.
   PubMed Web of Science ®Google Scholar
• [NFSA] Norwegian Food Safety Authority. 2012. Risk profile methyl salicylate CAS no. 119-36-8.
   Google Scholar
• [NRC] National Research Council of the National Academies. 2014. Review of EPA’s Integrated Risk Information (IRIS) Process. Committee to Review the IRIS Process Board on Environmental Studies and Toxicology Division on Earth and Life Studies.
   Google Scholar
• [NTP] National Toxicology Program. 1984. Abstract for RACB82104 – Methyl salicylate CAS no. 119-36-8. NTIS #RACB82104. Available from: http://ntp.niehs.nih.gov/testing/types/repro/abstracts/racb/index-8.html.
   Google Scholar
• Opdyke DL. 1978. Acute oral toxicity: rat; acute dermal toxicity: rabbit; and primary dermal irritation: rabbit for methyl salicylate, fragrance raw materials monographs. Food Cosmet Toxicol. 16:821–825.
   Google Scholar
• Opdyke DL. 1979a. Monographs on fragrance raw materials. Food Cosmet Toxicol. 17:357–390.
   PubMedGoogle Scholar
• Opdyke DL. 1979b. Monographs on fragrance raw materials. Food Cosmet Toxicol. 17:(Special Issue V):695–923.
   PubMedGoogle Scholar
• Overman DO, White JA. 1983. Comparative teratogenic effects of methyl salicylate applied orally or topically to hamsters. Teratology. 28:421–426.
   PubMedGoogle Scholar
• Packman EW, Abbott DD, Wagner BM, Harrisson JWE. 1961. Chronic oral toxicity of oil sweet birch (methyl salicylate). Pharmacologist. 3:62 (As cited in CIR 2003).
   Google Scholar
• Patrono C, Coller B, Dalen J, Fitzgerald G, Fuster V, Gent M, Hirsh J, Roth G. 2001. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest. 119(1 Suppl):39S–63S.
   PubMed Web of Science ®Google Scholar
• Rainsford K. 2004a. History and development of the salicylates. In: Rainsford K, editor. In aspirin and related drugs. New York: Taylor and Francis; p. 1–24.
   Google Scholar
• Rainsford K. 2004b. Pharmacology and biochemistry of salicylates and related drugs. In: Rainsford K, editor. In aspirin and related drugs. New York: Taylor and Francis; p. 215–366.
   Google Scholar
• Rainsford K. 2004c. Side effects and toxicology of the salicylates. In: Rainsford K, editor. In aspirin and related drugs. New York: Taylor and Francis; p. 367–554.
   Google Scholar
• Roberts LJIII, Morrow JD. 2001. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics. New York, (NY): McGraw-Hill; p. 687–729.
   Google Scholar
• Rotilio D, Joseph D, Hatmi M, Vargaftig B. 1984. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: additional evidence for distinct enzymatic sites. Eur J Pharmacol. 97:197–208.
   PubMed Web of Science ®Google Scholar
• Rudolph AM. 1981. Effects of aspirin and acetaminophen in pregnancy and in the newborn. Arch Intern Med. 141:358–363.
   PubMedGoogle Scholar
• Sharpe GL, Larsson KS, Thalme B. 1975. Studies on closure of the ductus arteriosus. XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits. Prostaglandins. 9:585–596.
   PubMed Web of Science ®Google Scholar
• Ungvary G, Tatrai E, Lorincz M, Barcza G. 1983. Combined embryotoxic action of toluene, a widely used industrial chemical, and acetylsalicylic acid (aspirin). Teratology. 27:261–269.
   PubMedGoogle Scholar
• [USEPA] United States Environmental Protection Agency. 1985. Reference values for risk assessment. United States Environmental Protection Agency, Washington, (DC): Environmental Criteria and Assessment Office.
   Google Scholar
• [USEPA] United States Environmental Protection Agency. 1988. Research and Development: General Quantitative Risk Assessment Guidelines for Noncancer Health Effects. Prepared for Risk Assessment Forum. Sixth Draft. ECAD-CIN-538.
   Google Scholar
• [USEPA] United States Environmental Protection Agency. 1993. Reference dose (RfD): Description and use in health risk assessments. Background document 1A, March 15, 1993. Integrated Risk Information System (IRIS), United States Environmental Protection Agency. Available from: http://www.epa.gov/iris/rfd.htm.
   Google Scholar
• [USEPA] United States Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. United States Environmental Protection Agency, Office of Research and Development. EPA/600/8 90/066F.
   Google Scholar
• [USEPA] United States Environmental Protection Agency. 2002. A review of the reference dose and reference concentration processes. Final report. Risk Assessment Forum, United States Environmental Protection Agency, Washington, DC. EPA/630/P-02/002F.
   Google Scholar
• [USEPA] United States Environmental Protection Agency. 2005a. Reregistration eligibility decision for methyl salicylate. United States Environmental Protection Agency. OPP Chemical Code: 076601. Issued September 27, 2005.
   Google Scholar
• [USEPA] United States Environmental Protection Agency. 2005b. Guidelines for carcinogen risk assessment. United States Environmental Protection Agency. EPA/630/P-03/001F.
   Google Scholar
• [USEPA] Untied States Environmental Protection Agency. 2011a. Recommended Use of BW3/4 as the Default Method in Derivation of the Oral Reference Dose. EPA/100/R11/001.
   Google Scholar
• [USEPA] Untied States Environmental Protection Agency. 2011b. Exposure Factors Handbook: 2011 Edition. EPA/600/R-090/052F. Available at: Available from: https://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid =236252.
   Google Scholar
• [USEPA] United States Environmental Protection Agency. 2012. Benchmark Dose Technical Guidance. Risk Assessment Forum. United States Environmental Protection Agency. EPA/100/R-12/001.
   Google Scholar
• [USEPA] Untied States Environmental Protection Agency. 2016 Benchmark Dose Software (BMDS). Available at: https://www.epa.gov/bmds.
   Google Scholar
• [USFDA] United States Food and Drug Administration. 1966. Chronic oral toxicity study of Methyl Salicylate using dogs and reproductive and developmental effects oral study of Methyl Salicylate using rats. Studies dated May. Submitted by FDA in response to an FOI request – 1998; 33 pages (As cited in CIR 2003).
   Google Scholar
• Vane JR, Botting RM. 2003. The mechanism of action of aspirin. Thromb Res. 110:255–258.
   PubMed Web of Science ®Google Scholar
• Verstraelen S, Nelissen I, Hooyberghs J, Witters H, Schoeters G, Van Cauwenberge P, Van Den Heuvel R. 2009a. Gene profiles of a human alveolar epithelial cell line after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol Lett. 185:16–22.
   PubMed Web of Science ®Google Scholar
• Verstraelen S, Nelissen I, Hooyberghs J, Witters H, Schoeters G, Van Cauwenberge P, Van Den Heuvel R. 2009b. Gene profiles of a human bronchial epithelial cell line after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicology. 255:151–159.
   PubMed Web of Science ®Google Scholar
• Vigano G, Garagiola U, Gaspari F. 1991. Pharmacokinetic study of a new oral buffered acetylsalicylic acid (ASA) formulation in comparison with plain ASA in healthy volunteers. Int J Clin Pharm Res. 11:129–135.
   PubMedGoogle Scholar
• Warknay J, Takacas E. 1959. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol. 35:315–331.
   PubMed Web of Science ®Google Scholar
• Webb WK, Hansen WH. 1963. Chronic and subacute toxicology and pathology of methyl salicylate in dogs, rats, and rabbits. Toxicol Appl Pharm. 5:576–587.
   PubMed Web of Science ®Google Scholar
• Wolowich WR, Hadley CM, Kelley M, Walson P, Casavant M. 2003. Plasma salicylate from methyl salicylate cream compared to oil of wintergreen. J Toxicol-Clin Toxic. 41:355–358.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Jia C, Hu Y, Sun L, Jiao J, Zhao L, Zhu D, LI J, Tian Y, Bai H, et al. 2012. The estrogenic potential of salicylate esters and their possible risks in foods and cosmetics. Toxicol Lett. 209:146–153.
   PubMed Web of Science ®Google Scholar